Fujian Quanzhou Xiaochaimi Trading Co., Ltd. – Trademark Portfolio

Entity Type: 99

Fujian Quanzhou Xiaochaimi Trading Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include CARMUJIN and FUNPISEA. The owner is based in Quanzhou City,Fujian.

Rm 307,Bldg 5,No.18 Xiangbin St,Bincheng

Community,Donghai St,Fengze Dist

Quanzhou City,Fujian 362000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CARMUJIN
CARMUJIN
Registered 2021
FUNPISEA
FUNPISEA
Registered 2021

Trademark Classifications

Fujian Quanzhou Xiaochaimi Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (2 filings)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Fujian Quanzhou Xiaochaimi Trading Co., Ltd. have?

Fujian Quanzhou Xiaochaimi Trading Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Fujian Quanzhou Xiaochaimi Trading Co., Ltd. file in?

Fujian Quanzhou Xiaochaimi Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 25 (Clothing). Class 25 covers clothing, footwear, headgear.

What are Fujian Quanzhou Xiaochaimi Trading Co., Ltd.'s most well-known trademarks?

Fujian Quanzhou Xiaochaimi Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as CARMUJIN and FUNPISEA. These are among 2 currently registered trademarks in the portfolio.

What is Fujian Quanzhou Xiaochaimi Trading Co., Ltd.'s trademark registration success rate?

Fujian Quanzhou Xiaochaimi Trading Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.